The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation

Somaia Mitne1,2, Sergio Henrique Teixeira1, Michal Schwartz3, Michael Belkin4, Michel Eid Farah1, Nilva S Bueno de Moraes1, Luciana da Cruz N&oacute;ia1, &Acirc;ngela Tavares Paes2, Cl&aacute;udio Luiz Lottenberg2, Augusto Paranhos J&uacute;nior1,21Department of Ophth...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mitne S, Teixeira SH, Schwartz M, Belkin M, Farah ME, Moraes N, N&oacute;ia LC, Paes AT, Lottenberg CL, Paranhos Jr A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/9d2a659c739f48d3aaf7d903c49ad408
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9d2a659c739f48d3aaf7d903c49ad408
record_format	dspace
spelling	oai:doaj.org-article:9d2a659c739f48d3aaf7d903c49ad4082021-12-02T04:30:52ZThe potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation1177-54671177-5483https://doaj.org/article/9d2a659c739f48d3aaf7d903c49ad4082011-07-01T00:00:00Zhttp://www.dovepress.com/the-potential-neuroprotective-effects-of-weekly-treatment-with-glatira-a7883https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Somaia Mitne1,2, Sergio Henrique Teixeira1, Michal Schwartz3, Michael Belkin4, Michel Eid Farah1, Nilva S Bueno de Moraes1, Luciana da Cruz N&oacute;ia1, &Acirc;ngela Tavares Paes2, Cl&aacute;udio Luiz Lottenberg2, Augusto Paranhos J&uacute;nior1,21Department of Ophthalmology, Federal University of S&atilde;o Paulo, 2Instituto Israelita de Ensino e Pesquisa Albert Einstein, HIAE, S&atilde;o Paulo, Brazil; 3Department of Neurobiology, The Weizmann Institute of Science, Rehovot, 4Goldschleger Eye Research Institute, Tel-Aviv University, Sheba Medical Center, Tel HaShomer, IsraelPurpose: Evaluation of the neuroprotective effect of weekly glatiramer acetate (GA) on retinal structure and function in diabetic patients who underwent panretinal photocoagulation (PRP).Patients and methods: Patients with severe nonproliferative or early proliferative diabetic retinopathy and no previous laser treatment were randomly divided into two groups: (1) those who received four GA treatments and (2) those who received placebo treatment. The subcutaneous injections were administered 1 week prior to laser and weekly in the subsequent three sessions of PRP in both groups. All patients underwent a full ophthalmic examination (best-corrected logMAR visual acuity, slit lamp examination, applanation tonometry, fundus biomicroscopy and indirect fundus examination); functional examination (standard automated perimetry, electroretinography and frequency-doubling technology C-20 visual field) and anatomic examination (color photography, optical coherence tomography (OCT) and Heidelberg retinal tomography). The examinations were performed before the photocoagulation and repeated 1,3,6, and 12 months after treatment (in a double-masked manner). To compare the two groups, generalized estimating equation models were performed to account for the dependence between eyes of the same patient.Results: Thirteen patients (23 eyes) were included in the study group and 13 patients (24 eyes) were included in the control group. OCT showed a statistically significant difference in retinal nerve fiber layer (RNFL) thickness in the inferior peripapillary region and average thickness with thinner measurements in the control group at 1-year post-PRP. Functional analysis demonstrated a difference between groups, but it did not reach statistical significance.Conclusion: The results of this study suggest that weekly GA treatment has a potential neuroprotective effect on the RNFL following photocoagulation for diabetic retinopathy.Keywords: diabetic retinopathy, panretinal photocoagulation, glatiramer acetate, neuroprotection &nbsp;Mitne STeixeira SHSchwartz MBelkin MFarah MEMoraes NN&oacute;ia LCPaes ATLottenberg CLParanhos Jr ADove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 991-997 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Mitne S Teixeira SH Schwartz M Belkin M Farah ME Moraes N N&oacute;ia LC Paes AT Lottenberg CL Paranhos Jr A The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation
description	Somaia Mitne1,2, Sergio Henrique Teixeira1, Michal Schwartz3, Michael Belkin4, Michel Eid Farah1, Nilva S Bueno de Moraes1, Luciana da Cruz N&oacute;ia1, &Acirc;ngela Tavares Paes2, Cl&aacute;udio Luiz Lottenberg2, Augusto Paranhos J&uacute;nior1,21Department of Ophthalmology, Federal University of S&atilde;o Paulo, 2Instituto Israelita de Ensino e Pesquisa Albert Einstein, HIAE, S&atilde;o Paulo, Brazil; 3Department of Neurobiology, The Weizmann Institute of Science, Rehovot, 4Goldschleger Eye Research Institute, Tel-Aviv University, Sheba Medical Center, Tel HaShomer, IsraelPurpose: Evaluation of the neuroprotective effect of weekly glatiramer acetate (GA) on retinal structure and function in diabetic patients who underwent panretinal photocoagulation (PRP).Patients and methods: Patients with severe nonproliferative or early proliferative diabetic retinopathy and no previous laser treatment were randomly divided into two groups: (1) those who received four GA treatments and (2) those who received placebo treatment. The subcutaneous injections were administered 1 week prior to laser and weekly in the subsequent three sessions of PRP in both groups. All patients underwent a full ophthalmic examination (best-corrected logMAR visual acuity, slit lamp examination, applanation tonometry, fundus biomicroscopy and indirect fundus examination); functional examination (standard automated perimetry, electroretinography and frequency-doubling technology C-20 visual field) and anatomic examination (color photography, optical coherence tomography (OCT) and Heidelberg retinal tomography). The examinations were performed before the photocoagulation and repeated 1,3,6, and 12 months after treatment (in a double-masked manner). To compare the two groups, generalized estimating equation models were performed to account for the dependence between eyes of the same patient.Results: Thirteen patients (23 eyes) were included in the study group and 13 patients (24 eyes) were included in the control group. OCT showed a statistically significant difference in retinal nerve fiber layer (RNFL) thickness in the inferior peripapillary region and average thickness with thinner measurements in the control group at 1-year post-PRP. Functional analysis demonstrated a difference between groups, but it did not reach statistical significance.Conclusion: The results of this study suggest that weekly GA treatment has a potential neuroprotective effect on the RNFL following photocoagulation for diabetic retinopathy.Keywords: diabetic retinopathy, panretinal photocoagulation, glatiramer acetate, neuroprotection &nbsp;
format	article
author	Mitne S Teixeira SH Schwartz M Belkin M Farah ME Moraes N N&oacute;ia LC Paes AT Lottenberg CL Paranhos Jr A
author_facet	Mitne S Teixeira SH Schwartz M Belkin M Farah ME Moraes N N&oacute;ia LC Paes AT Lottenberg CL Paranhos Jr A
author_sort	Mitne S
title	The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation
title_short	The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation
title_full	The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation
title_fullStr	The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation
title_full_unstemmed	The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation
title_sort	potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/9d2a659c739f48d3aaf7d903c49ad408
work_keys_str_mv	AT mitnes thepotentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT teixeirash thepotentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT schwartzm thepotentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT belkinm thepotentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT farahme thepotentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT moraesn thepotentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT nampoacuteialc thepotentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT paesat thepotentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT lottenbergcl thepotentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT paranhosjra thepotentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT mitnes potentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT teixeirash potentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT schwartzm potentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT belkinm potentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT farahme potentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT moraesn potentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT nampoacuteialc potentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT paesat potentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT lottenbergcl potentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation AT paranhosjra potentialneuroprotectiveeffectsofweeklytreatmentwithglatirameracetateindiabeticpatientsafterpanretinalphotocoagulation
_version_	1718401205425668096

The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation

Ejemplares similares